Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -10.08% is 54% above its 5-year average of -21.70%, near the high end of its 5-year range (-69.39%–-8.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 43.30% above its 12-month average of -17.78%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -10.08%.
RETURN ON EQUITY (ROE)
-10.08%
RETURN ON EQUITY (ROE) AVG TTM
-17.78%
RETURN ON EQUITY (ROE) AVG 3Y
-37.20%
RETURN ON EQUITY (ROE) AVG 5Y
-21.70%
RETURN ON EQUITY (ROE) AVG 10Y
-15.33%
RETURN ON EQUITY (ROE) AVG 15Y
0.21%
RETURN ON EQUITY (ROE) AVG 20Y
4.54%
CURRENT VS TTM AVG
+43.30%
CURRENT VS 3Y AVG
+72.90%
CURRENT VS 5Y AVG
+53.54%
CURRENT VS 10Y AVG
+34.23%
CURRENT VS 15Y AVG
-4966.73%
CURRENT VS 20Y AVG
-322.06%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
+76.01%
vs the sector median at left
KORU Medical Systems, Inc.
Market Cap
$137.80M
Return on Equity (ROE)
-10.08%
TTM Avg
-17.78%
3Y Avg
-37.20%
5Y Avg
-21.70%
Market Cap
$136.67M
Return on Equity (ROE)
-43.42%
TTM Avg
-36.99%
3Y Avg
-36.99%
5Y Avg
-36.99%
Market Cap
$136.57M
Return on Equity (ROE)
15.55%
TTM Avg
-9.97%
3Y Avg
-34.81%
5Y Avg
-26.89%
Market Cap
$139.04M
Return on Equity (ROE)
-30.03%
TTM Avg
-86.56%
3Y Avg
-69.53%
5Y Avg
-37.30%
Market Cap
$139.47M
Return on Equity (ROE)
-44.26%
TTM Avg
-34.18%
3Y Avg
285.39%
5Y Avg
-5868.11%
Market Cap
$139.84M
Return on Equity (ROE)
N/A
TTM Avg
-182.86%
3Y Avg
-123.00%
5Y Avg
-90.58%
Market Cap
$143.10M
Return on Equity (ROE)
-120.33%
TTM Avg
-117.87%
3Y Avg
-76.44%
5Y Avg
-55.77%
Market Cap
$132.03M
Return on Equity (ROE)
-266.86%
TTM Avg
156.76%
3Y Avg
98.17%
5Y Avg
-694.29%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | $137.80M | -10.08% | -17.78% | -37.20% | -21.70% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | -43.42% | -36.99% | -36.99% | -36.99% |
| Organigram Global Inc. (OGI)vs › | $136.57M | 15.55% | -9.97% | -34.81% | -26.89% |
| Immuneering Corporation (IMRX)vs › | $139.04M | -30.03% | -86.56% | -69.53% | -37.30% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -44.26% | -34.18% | 285.39% | -5868.11% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | N/A | -182.86% | -123.00% | -90.58% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -120.33% | -117.87% | -76.44% | -55.77% |
| LifeMD, Inc. (LFMD)vs › | $132.03M | -266.86% | 156.76% | 98.17% | -694.29% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | -43.40% | -27.96% | -44.92% | -37.65% |
ROE
-10.1%
ROA
-6.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -10.08% |
| 2026-03-31 | -13.47% |
| 2025-12-31 | -15.47% |
| 2025-09-30 | -22.55% |
| 2025-06-30 | -27.32% |
| 2025-03-31 | -32.41% |
| 2024-12-31 | -36.08% |
| 2024-09-30 | -67.51% |
| 2024-06-30 | -62.87% |
| 2024-03-31 | -69.39% |
| 2023-12-31 | -67.51% |
| 2023-09-30 | -30.08% |
| 2023-06-30 | -28.86% |
| 2023-03-31 | -28.64% |
| 2022-12-31 | -27.65% |
| 2022-09-30 | -23.86% |
| 2022-06-30 | -23.36% |
| 2022-03-31 | -16.74% |
| 2021-12-31 | -12.50% |
| 2021-09-30 | -11.76% |
| 2021-06-30 | -8.01% |
| 2021-03-31 | -7.77% |
| 2020-12-31 | -3.35% |
| 2020-09-30 | -1.15% |
| 2020-06-30 | -0.14% |
| 2020-03-31 | 9.06% |
| 2019-12-31 | 5.02% |
| 2019-09-30 | 2.63% |
| 2019-06-30 | 0.25% |
| 2019-03-31 | 4.60% |
| 2018-12-31 | 10.16% |
| 2018-09-30 | 19.81% |
| 2018-06-30 | 19.44% |
| 2018-03-31 | 16.78% |
| 2017-02-28 | -8.01% |
| 2016-11-30 | -1.12% |
| 2016-08-31 | 2.89% |
| 2016-05-31 | 8.85% |
| 2016-02-29 | 11.00% |
| 2015-11-30 | 10.89% |
| 2015-08-31 | 10.10% |
| 2015-05-31 | 8.53% |
| 2015-02-28 | 12.00% |
| 2014-11-30 | 13.87% |
| 2014-08-31 | 15.28% |
| 2014-05-31 | 14.64% |
| 2014-02-28 | 13.55% |
| 2013-11-30 | 11.60% |
| 2013-08-31 | 9.76% |
| 2013-05-31 | 15.85% |
| 2013-02-28 | 16.66% |
| 2012-11-30 | 19.92% |
| 2012-08-31 | 23.57% |
| 2012-05-31 | 19.45% |
| 2012-02-29 | 22.98% |
| 2011-11-30 | 25.60% |
| 2011-08-31 | 26.62% |
| 2011-05-31 | 30.38% |
| 2011-02-28 | 28.39% |
| 2010-11-30 | 47.81% |
| 2010-08-31 | 46.17% |
| 2010-05-31 | 51.42% |
| 2010-02-28 | 52.66% |
| 2009-11-30 | 70.20% |
| 2009-08-31 | 88.06% |
| 2009-05-31 | 133.95% |
| 2009-02-28 | 146.22% |
| 2008-11-30 | 84.94% |
| 2003-05-31 | -748.13% |
